Industry Overview

US medical device technology market was valued at $182.5 billion in 2025 and is projected to reach $287.5 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2026–2035). The medical device market in the US remains a global powerhouse, fueled by high healthcare expenditure, advanced clinical infrastructure, and strong innovation ecosystems. Hospitals and clinics across the country are rapidly adopting next?generation diagnostic tools, imaging systems, and minimally invasive devices to meet rising demand. Significant investments in research and development by leading manufacturers support the continuous introduction of cutting?edge equipment. Growth is further driven by expanding insurance coverage and increased focus on preventive and personalized care. As a result, the market is growing both in scale and technological sophistication, maintaining the US as a leading hub for global med?tech deployment.

Market Dynamics

Surge in AI?Driven Diagnostics and Imaging

Artificial intelligence (AI) integration is transforming diagnostic and imaging devices across the U.S. medical technology landscape. Devices combining AI-powered image reconstruction, automated lesion detection, and workflow optimization are becoming standard, enabling faster, more reliable diagnosis while reducing clinician workload. Regulatory approvals and growing trust in AI-assisted results are encouraging broader adoption. As a result, diagnostic accuracy and throughput are improving, helping hospitals manage increasing patient loads efficiently. This trend underscores a shift toward smarter, data?driven diagnostics becoming central to U.S. healthcare deployment.

Rise of Minimally Invasive and Image-Guided Therapeutics

Minimally invasive procedures and image-guided therapies are increasingly preferred in the US, as they offer shorter recovery times and lower post?operative complications compared to traditional surgery. Demand for advanced endovascular tools, robotic-assisted systems, and guided?therapy platforms continues to rise. Hospitals are investing in equipment that allows precise navigation and lower-risk interventions. This shift is supported by patient demand for less invasive care and by providers seeking to improve efficiency and outcomes. As a result, the therapeutic device segment is gaining strong momentum and evolving rapidly to meet modern care standards.

Market Segmentation

• Based on the device type, the market is segmented into in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, and others.

In?Vitro Diagnostics Devices Segment to Lead the Market with the Largest Share

The in?vitro diagnostics (IVD) segment in the US remains a foundational element of the medical device market. Rising prevalence of chronic and infectious diseases, along with growing emphasis on early detection and preventive care, drives demand for advanced lab instruments, molecular assays, and point?of?care systems. The prominent companies in the market, such as Abbott Laboratories, Roche, Thermo Fisher Scientific, and Beckman Coulter, continue to enhance their portfolios with high-throughput analyzers and integrated diagnostic platforms. Recent trends include automation, digital reporting, and remote connectivity, all enhancing lab efficiency, speed, and accuracy. As healthcare evolves toward value-based and preventive models, IVD devices are becoming increasingly central to patient care pathways.

Diagnostic Imaging Devices: A Key Segment in Market Growth

Diagnostic imaging remains one of the largest and fastest-evolving segments in the US market. Demand for MRI, CT, ultrasound, and digital X-ray systems continues to grow, as healthcare providers look to support early disease detection, precise diagnostics, and effective treatment planning. Leading manufacturers such as GE HealthCare, Philips, Siemens Healthineers, and Canon Medical Systems supply advanced imaging solutions that include improved resolution, reduced radiation exposure, and compact designs suitable for diverse clinical settings. Notably, integration of AI-enabled image processing and cloud-based storage is increasing, allowing faster diagnosis and better image management trends that reinforce imaging’s role as a backbone of modern diagnostics.

Market Players Outlook

The major companies operating in the US medical device technology market include Medtronic plc, Abbott Laboratories, Boston Scientific Corp., Stryker Corp., and GE HealthCare, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In December 2025, Royal Philips announced the expanded commercial availability of LumiGuide 3D Device Guidance, the world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy, across Europe and the US. LumiGuide represents a breakthrough in radiation-free* navigation, allowing physicians to visualize and guide devices inside the body using light instead of continuous X-ray. Announced at RSNA 2025, the wider commercial rollout marks the next step in Philips’ long-term commitment to improving radiation safety and dose reduction in image-guided therapy.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the US medical device technology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.